Raise money for people with ALS with polar plunge in the frigid Atlantic this weekend
The Valentine Plunge has raised nearly $5 million for the Joan Dancy and P.A.L.S. (People with ALS) Foundation.
Neurizon granted US patent for lead drug to treat motor neurone and other neurodegenerative conditions
Neurizon Therapeutics has achieved a key milestone with a patent granted in the US for its lead drug candidate NUZ-001 to ...
PathMaker Neurosystems Announces IRB Approval for DoD-funded Clinical Trial of the MyoRegulator Device in ALS
Nader Yaghoubi, M.D., Ph.D., PathMaker’s Co-Founder and CEO, stated, “We are pleased to announce IRB approval for the CALM study, which allows us to commence enrollments shortly. Given the mechanisms ...
Wake County deputy’s career cut short by ALS. Will the county help him and his family?
Roy Woodlief, center, poses with Wake County Sheriff Donnie Harrison and Terry Putnam after Woodlief graduated the academy ...
KTTC4d
Father diagnosed with ALS and son prepare for Boston Marathon
Competing in a marathon could be considered quite the task for some, but not for one Amyotrophic Lateral Sclerosis (ALS) ...
Woman Ends Her Life After ALS Diagnosis, Chooses Medical Aid in Dying: 'I Don't Want More Time as a Patient'
Barbara Goodfriend, 83, opted for medical aid in dying after being diagnosed with ALS. The New Jersey widow ended her life in ...
FierceBiotech5d
Kadimastem gets shareholder backing for NLS merger, advancing once-thwarted push for Nasdaq listing
Kadimastem’s attempt to vault onto Nasdaq is picking up momentum, with shareholders signing off on a merger with NLS Pharmaceutics that would enable the cell therapy developer to recover from last ...
Clene Inc. secures additional NIH grant funds for ALS therapy
Salt Lake City-based pharmaceutical company Clene Inc. has amended its grant subaward with Columbia University, securing up ...
clinicaladvisor.com6d
Real-World Study Suggests Fewer ALS Progression Milestones With Edaravone
A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.